Back
Results - Announcements
Jeevan Scientific Technology Ltd consolidated sales down 14.14% on year in Q2FY2026, net profit tumbled by 52.72%
13-Aug-2026, 05:23
Jeevan Scientific Technology Ltd share price declined by 2.33% to Rs 78.52 after the company's net profit witnessed a sharp fall of 52.72% to Rs 0.87 crore, while revenue from operations reduced 14.14% to Rs 18.28 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Research, Analytics & Technology industry group stocks on BSE stood at Rs 39847.85 crore, retreating 13.17%. It has marginally improved by 2.14% over last one week and heading higher by 9.92% in last one month while the market capitalization of Jeevan Scientific Technology Ltd has softened by 2.39% and 5.67% in the same period respectively. Profit before tax (PBT) of Jeevan Scientific Technology Ltd stood at Rs 0.98 crore in Q2 FY26, plunging by 126.27% year-on-year, and crashing by 61.72% quarter-on-quarter. EBITDA came in at Rs 3 crore, nosediving by 231.75% YoY and tanking 30.67% sequentially. Total expenses eased by 8.39% to Rs 17.03 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 1.71 crore, inching up 5.56% YoY, while employee benefits expense was at Rs 5.74 crore, slipping by 3.85% YoY. For the TTM ended FY26, revenue from operations improved 18.13% to Rs 46.84 crore, while net profit tanked by 104.51% to Rs 0.06 crore, compared to previous TTM. EBITDA soared by 327% to Rs 6.76 crore, and PBT collapsed by 103.13% to Rs 0.05 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 10.07 crore in FY26, as against Rs 2.89 crore in FY25. Jeevan Scientific Technology Ltd jumped 86.46% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.83% during the same period.
Jeevan Scientific Technology Ltd share price declined by 2.33% to Rs 78.52 after the company's net profit witnessed a sharp fall of 52.72% to Rs 0.87 crore, while revenue from operations reduced 14.14% to Rs 18.28 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Research, Analytics & Technology industry group stocks on BSE stood at Rs 39847.85 crore, retreating 13.17%. It has marginally improved by 2.14% over last one week and heading higher by 9.92% in last one month while the market capitalization of Jeevan Scientific Technology Ltd has softened by 2.39% and 5.67% in the same period respectively. Profit before tax (PBT) of Jeevan Scientific Technology Ltd stood at Rs 0.98 crore in Q2 FY26, plunging by 126.27% year-on-year, and crashing by 61.72% quarter-on-quarter. EBITDA came in at Rs 3 crore, nosediving by 231.75% YoY and tanking 30.67% sequentially. Total expenses eased by 8.39% to Rs 17.03 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 1.71 crore, inching up 5.56% YoY, while employee benefits expense was at Rs 5.74 crore, slipping by 3.85% YoY. For the TTM ended FY26, revenue from operations improved 18.13% to Rs 46.84 crore, while net profit tanked by 104.51% to Rs 0.06 crore, compared to previous TTM. EBITDA soared by 327% to Rs 6.76 crore, and PBT collapsed by 103.13% to Rs 0.05 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 10.07 crore in FY26, as against Rs 2.89 crore in FY25. Jeevan Scientific Technology Ltd jumped 86.46% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.83% during the same period.